Lifecore Biomedical (LFCR) News Today $7.48 +0.39 (+5.50%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge fundsNovember 13, 2024 | finance.yahoo.comLifecore Biomedical to Present at Stephens Annual Investment ConferenceNovember 12, 2024 | globenewswire.comLifecore Biomedical: Finally A 'Pure Play' CDMO BusinessNovember 12, 2024 | seekingalpha.comLifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024November 7, 2024 | globenewswire.comLifecore Biomedical (NASDAQ:LFCR) Stock Price Up 4.5% - Here's WhyLifecore Biomedical (NASDAQ:LFCR) Trading 4.5% Higher - What's Next?November 7, 2024 | marketbeat.comLifecore appoints Guldager as vice president, operationsNovember 5, 2024 | markets.businessinsider.comLifecore Biomedical Appoints Thomas Guldager as Vice President, OperationsNovember 4, 2024 | globenewswire.comChaska’s Lifecore looks to growth in coming years after emerging from delisting challengeNovember 1, 2024 | startribune.comJohnson Fistel LLP Investigates Lifecore Biomedical, Inc's Directors and Officers for Breach of Fiduciary Duties and Encourages Long Term Shareholders to Reach Out for Their OptionsOctober 11, 2024 | globenewswire.comQ3 2025 EPS Estimates for Lifecore Biomedical, Inc. (NASDAQ:LFCR) Lifted by Barrington ResearchLifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Analysts at Barrington Research boosted their Q3 2025 earnings estimates for shares of Lifecore Biomedical in a research report issued on Monday, October 7th. Barrington Research analyst M. Petusky now anticipates that the company will postOctober 9, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR)Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Equities research analysts at Barrington Research issued their Q1 2026 EPS estimates for shares of Lifecore Biomedical in a note issued to investors on Monday, October 7th. Barrington Research analyst M. Petusky forecasts that the company wiOctober 8, 2024 | marketbeat.comLifecore Biomedical: A Cautious Hold Amid Modest Growth and Financial ChallengesOctober 8, 2024 | markets.businessinsider.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call TranscriptOctober 8, 2024 | msn.comLegion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical IncOctober 8, 2024 | finance.yahoo.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Buys $504,013.00 in StockOctober 8, 2024 | insidertrades.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Marshall Wace LLPMarshall Wace LLP increased its holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 87.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 300,120 shares of the company's stock after purOctober 6, 2024 | marketbeat.comLifecore Raises Millions in Common StockOctober 5, 2024 | baystreet.caOptions Volatility and Implied Earnings Moves Today, October 04, 2024October 5, 2024 | msn.comLifecore Biomedical, Inc. (LFCR) Q1 2025 Earnings Call TranscriptOctober 5, 2024 | seekingalpha.comLifecore Biomedical Raises $24.3 Million in Private Placement of Common StockOctober 5, 2024 | finance.yahoo.comLifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate UpdateOctober 4, 2024 | globenewswire.comLifecore Biomedical (LFCR) Receives a Buy from Craig-HallumOctober 4, 2024 | markets.businessinsider.comLifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024October 3, 2024 | globenewswire.comLifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation TechnologyOctober 1, 2024 | globenewswire.comLFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 27, 2024 | globenewswire.comLFCR DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCRSeptember 26, 2024 | globenewswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)September 26, 2024 | tmcnet.comFINAL LFCR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Lifecore Biomedical, Inc. Investors to Join the Class Action Lawsuit!September 26, 2024 | markets.businessinsider.comLFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud LawsuitSeptember 25, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifecoreSeptember 25, 2024 | globenewswire.comLifecore Biomedical to Participate at Upcoming Industry Conferences and EventsSeptember 25, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lifecore Biomedical, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFCRSeptember 25, 2024 | prnewswire.comLFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law FirmSeptember 25, 2024 | prnewswire.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)September 24, 2024 | globenewswire.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Sold by 272 Capital LP272 Capital LP lessened its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 83.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 23,478 shares of the company's stock after selling 121,981 shares during the quarter. 272September 24, 2024 | marketbeat.comLFCR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCRSeptember 23, 2024 | globenewswire.comLifecore Biomedical, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 27, 2024 Deadline to file Lead Plaintiff MotionSeptember 23, 2024 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifecoreSeptember 23, 2024 | prnewswire.comLFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 22, 2024 | globenewswire.comLFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud LawsuitSeptember 22, 2024 | prnewswire.comLFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud LawsuitSeptember 20, 2024 | prnewswire.comLFCR DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCRSeptember 20, 2024 | globenewswire.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifecoreSeptember 19, 2024 | globenewswire.comLifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and OperationalSeptember 19, 2024 | globenewswire.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)September 18, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lifecore Biomedical, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFCRSeptember 17, 2024 | prnewswire.comLFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud LawsuitSeptember 17, 2024 | prnewswire.comFaruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024 - LFCRSeptember 17, 2024 | prnewswire.comLFCR DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCRSeptember 16, 2024 | globenewswire.comLFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 16, 2024 | globenewswire.com Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report... The Next SpaceX Pre-IPO LFCR Media Mentions By Week LFCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFCR News Sentiment▼0.400.45▲Average Medical News Sentiment LFCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFCR Articles This Week▼04▲LFCR Articles Average Week Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies American Vanguard News Today Seneca Foods News Today Oil-Dri Co. of America News Today Avadel Pharmaceuticals News Today Zymeworks News Today Septerna News Today Cogent Biosciences News Today Bicara Therapeutics News Today Bicycle Therapeutics News Today Collegium Pharmaceutical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFCR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
